Efficacy of Clinacanthus nutans Lindau cream comparing with podophyllin for treating anogenital warts among Thai males: A self-comparison, randomized controlled trial
Phase 1
Recruiting
- Conditions
- anogenital wartpodophyllinclinacanthus nutans lindau cream
- Registration Number
- TCTR20170621003
- Lead Sponsor
- Siriraj hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 12
Inclusion Criteria
1. male patients 18 years and older
2. diagnosed as anogenitalwart
3. at least two lesions of wart which are at least 1 cm apart
4. consent form obtained
Exclusion Criteria
1. patients with HIV infection
2. patients on immunosuppressive drugs
3. patients with autoimmune disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method size reduction of anogenital wart 4 week quantitative measurement(mm)
- Secondary Outcome Measures
Name Time Method viral loads of genital wart 4 week quantitative measurement(digital droplet PCR- Each droplet represents as 1 HPV DNA copy),gene expression of genital wart 4 week qualitative measurement(Nanostring technology- number of gene for log fold change compare to houseke,side effects of clinacanthus nutans lindau cream 4 week qualitative measurement(clinical symptoms- erythema, ulceration)